Keith Speights

Keith Speights


Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles

3 Top Cannabis Stocks to Buy Now

These cannabis stocks are profitable. They're growing rapidly. And they're great picks to buy right now.